The transcendIT-101 Trial is sponsored by Ascendis Pharma Oncology Division A/S. Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma Group. © February 2021 Ascendis Pharma A/S.

Protected: My Post

The content is password protected. To view
it please enter your password below: